Category: Ubiquitin proteasome pathway

Promising phase I trial results led to a phase II clinical trial involving the personalized cancer vaccine mRNA-4157 (NCT03897881) for the treatment of cutaneous melanoma [393]. and strategies. == Abstract == Immune checkpoint blockade (ICB) has emerged as a novel therapeutic tool for cancer therapy in the last decade. Unfortunately, a small number of patients…